News Detail
Boston, 13 Feb 2023: About 10% of drugs approved by the US Food and Drug Administration (FDA) between 2018 and 2021 had pivotal trials with null findings, according to a research letter published in JAMA Internal Medicine.
“Our findings underscore ......
View Details
Source : Regulatory News
drugs approved
US Food and Drug Administration
pivotal trials with null findings
JAMA Internal Medicine
new drug applications
Related News
- Study Identifies Hundreds of Potential Targets for Cancer Drugs (12-09-2024)
- Protein-lipid particles to deliver genetic medicine (11-09-2024)
- Harnessing bacteriophages as targeted treatments for drug-resistant bacteria (06-09-2024)
- Chinese scientists claim to have developed hydrogel to treat arthritis: Report (03-09-2024)
- Human gut microbiome: A source of new antibiotic peptides (26-08-2024)
- IIT Kanpur-KGMU together developed a special device, to give easily CPR at home (01-08-2024)
- Scientists control bacterial mutations to preserve antibiotic effectiveness (27-07-2024)
- Dual action antibiotic could make bacterial resistance nearly impossible (25-07-2024)
- Metoprolol, Tamsulosin and Bromocriptine combination treatment shows promise in the treatment of retinal degenerations (23-07-2024)
- Rotifer acquire genes from bacteria that can produce antibiotics (21-07-2024)